First-trimester levels of pregnancy-associated plasma protein A2 (PAPP-A2) in the maternal circulation are elevated in pregnancies that subsequently develop preeclampsia

Reproductive Sciences

Volumn 21, Issue 6, 2014, Pages 754-760

  Crosley, Erin J ^a   Durland, Ursula ^b   Seethram, Ken ^b   Macrae, Scott ^c   Gruslin, Andrée ^d   Christians, Julian K ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

^b Pacific Centre for Reproductive Medicine   (Canada)

^c PROVINCIAL HEALTH SERVICES AUTHORITY   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

PAPP A2; preeclampsia; small for gestational age

Indexed keywords

PREGNANCY ASSOCIATED PLASMA PROTEIN A2; PREGNANCY ASSOCIATED PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; PAPPA2 PROTEIN, HUMAN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MATERNAL SERUM; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMALL FOR DATE INFANT; UPREGULATION; BIOSYNTHESIS; BLOOD; PHYSIOLOGY; PLACENTA CIRCULATION; PRE-ECLAMPSIA; PREGNANCY; RETROSPECTIVE STUDY;

ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; PLACENTAL CIRCULATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RETROSPECTIVE STUDIES;

EID: 84900398441     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719113512532     Document Type: Article

References (41)

1. Cross JC. The genetics of pre-eclampsia: a feto-placental or maternal problem?. Clin Genet. 2003 ; 64 (2). 96-103
2. Kinzler WL, Vintzileos AM. Fetal growth restriction: a modern approach. Curr Opin Obstet Gynecol. 2008 ; 20 (2). 125-131
3. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005 ; 308 (5728). 1592-1594
4. von Dadelszen P, Magee L. What matters in preeclampsia are the associated adverse outcomes: the view from Canada. Curr Opin Obstet Gynecol. 2008 ; 20 (2). 110-115
5. Godfrey KM. The role of the placenta in fetal programming - a review. Placenta. 2002 ; 23 (suppl A). S20 - S27
6. Nayak NR, Giudice LC. Comparative biology of the IGF system in endometrium, decidua, and placenta, and clinical implications for foetal growth and implantation disorders. Placenta. 2003 ; 24 (4). 281-296
7. Sferruzzi-Perri AN, Owens JA, Pringle KG, Roberts CT. The neglected role of insulin-like growth factors in the maternal circulation regulating fetal growth. J Physiol. 2011 ; 589 (pt 1). 7-20
8. Baxter RC. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab. 2000 ; 278 (6). E967 - E976
9. Bunn RC, Fowlkes JL. Insulin-like growth factor binding protein proteolysis. Trends Endocrinol Metab. 2003 ; 14 (4). 176-181
10. Murphy LJ. Insulin-like growth factor-binding proteins: functional diversity or redundancy?. J Mol Endocrinol. 1998 ; 21 (2). 97-107
11. Giudice LC, Conover CA, Bale L, et al. Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation. J Clin Endocrinol Metab. 2002 ; 87: 2359-2366
12. Boldt HB, Kjaer-Sorensen K, Overgaard MT, et al. The Lin12-notch repeats of pregnancy-associated plasma protein-A bind calcium and determine its proteolytic specificity. J Biol Chem. 2004 ; 279: 38525-38531
13. Boldt HB, Conover CA. Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IGF bioavailability through cleavage of IGFBPs. Growth Horm IGF Res. 2007 ; 17: 10-18
14. Brambati B, Macintosh MC, Teisner B, et al. Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype. Br J Obstet Gynaecol. 1993 ; 100: 324-326
15. Bersinger NA, Odegard RA. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies. Acta Obstet Gynecol Scand. 2004 ; 83: 37-45
16. Dugoff L, Hobbins JC, Malone FD, et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol. 2004 ; 191: 1446-1451
17. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab. 2002 ; 87: 1762-1767
18. Spencer K, Yu CK, Cowans NJ, Otigbah C, Nicolaides KH. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn. 2005 ; 25: 949-953
19. Zwahlen M, Gerber S, Bersinger NA. First trimester markers for pre-eclampsia: placental vs. non-placental protein serum levels. Gynecol Obstet Invest. 2007 ; 63: 15-21
20. Cowans NJ, Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn. 2007 ; 27: 264-271
21. Zhong Y, Tuuli M, Odibo AO. First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenat Diagn. 2010 ; 30 (4). 293-308
22. Farr M, Strube J, Geppert HG, Kocourek A, Mahne M, Tschesche H. Pregnancy-associated plasma protein-E (PAPP-E). Biochim Biophys Acta. 2000 ; 1493 (3). 356-362
23. Page NM, Butlin DJ, Lomthaisong K, Lowry PJ. The characterization of pregnancy associated plasma protein-E and the identification of an alternative splice variant. Placenta. 2001 ; 22 (8-9). 681-687
24. Overgaard MT, Boldt HB, Laursen LS, Sottrup-Jensen L, Conover CA, Oxvig C. Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase. J Biol Chem. 2001 ; 276 (24). 21849-21853
25. Buimer M, Keijser R, Jebbink JM, et al. Seven placental transcripts characterize HELLP-syndrome. Placenta. 2008 ; 29 (5). 444-453
26. Sitras V, Paulssen RH, Gronaas H, et al. Differential placental gene expression in severe preeclampsia. Placenta. 2009 ; 30 (5). 424-433
27. Nishizawa H, Pryor-Koishi K, Suzuki M, et al. Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients. Mol Hum Reprod. 2008 ; 14 (10). 595-602
28. Winn VD, Gormley M, Paquet AC, et al. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology. 2009 ; 150 (1). 452-462
29. Paiva P, Whitehead C, Saglam B, Palmer K, Tong S. Measurement of mRNA transcripts of very high placental expression in maternal blood as biomarkers of preeclampsia. J Clin Endocrinol Metab. 2011 ; 96 (11). E1807 - E1815
30. Varkonyi T, Nagy B, Fule T, et al. Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. Placenta. 2011 ; 32 (suppl). S21 - S29
31. Macintire K, Tuohey L, Ye L, et al. PAPPA2 is increased in severe early onset pre-eclampsia and upregulated with hypoxia [published online March 14, 2013]. Reprod Fertil Dev. 2013 ;:
32. Dopierala JA, Smith GC, Charnock-Jones SD. Meta-analysis of pre-eclampsia microarray data. Reprod Sci. 2013 ; 20 (3 suppl). 262A
33. von Dadelszen P, Menzies JM, Payne B, Magee LA. Predicting adverse outcomes in women with severe pre-eclampsia. Semin Perinatol. 2009 ; 33 (3). 152-157
34. Wagner PK, Christians JK. Altered placental expression of PAPPA2 does not affect birth weight in mice. Reprod Biol Endocrinol. 2010 ; 8: 90
35. Wang J, Qiu Q, Haider M, Bell M, Gruslin A, Christians JK. Expression of pregnancy-associated plasma protein A2 during pregnancy in human and mouse. J Endocrinol. 2009 ; 202 (3). 337-345
36. Yan X, Baxter RC, Firth SM. Involvement of pregnancy-associated plasma protein-A2 in insulin-like growth factor (IGF) binding protein-5 proteolysis during pregnancy: a potential mechanism for increasing IGF bioavailability. J Clin Endocrinol Metab. 2010 ; 95 (3). 1412-1420
37. Christians JK, Gruslin A. Altered levels of insulin-like growth factor binding protein proteases in preeclampsia and intrauterine growth restriction. Prenat Diagn. 2010 ; 30 (9). 815-820
38. Wagner PK, Otomo A, Christians JK. Regulation of pregnancy-associated plasma protein A2 (PAPPA2) in a human placental trophoblast cell line (BeWo). Reprod Biol Endocrinol. 2011 ; 9: 48
39. Kramer A, Hoffman C, Lynch A, Winn VD. Maternal serum PAPP-A2 levels are elevated in early onset preeclampsia at time of diagnosis and in early gestation. Reprod Sci. 2012 ; 19 (3 suppl). 87A
40. Poon LC, Stratieva V, Piras S, Piri S, Nicolaides KH. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks. Prenat Diagn. 2010 ; 30 (3). 216-223
41. Whitehead CL, Walker SP, Ye L, et al. Placental specific mRNA in the maternal circulation are globally dysregulated in pregnancies complicated by fetal growth restriction. J Clin Endocrinol Metab. 2013 ; 98 (3). E429 - E436